Iontophoresis preparation for treating breast cancer and/or mastitis
    12.
    发明授权
    Iontophoresis preparation for treating breast cancer and/or mastitis 失效
    用于治疗乳腺癌和/或乳腺炎的离子电渗疗法

    公开(公告)号:US08442629B2

    公开(公告)日:2013-05-14

    申请号:US12988047

    申请日:2009-04-17

    IPC分类号: A61N1/30 A61K33/00

    摘要: Provided is to enhance the therapeutic effect of an iontophoretic preparation for treatment of breast cancer or mastitis.An iontophoretic preparation for treatment of breast cancer and/or mastitis containing, as an active ingredient, a nonsteroidal anti-inflammatory analgesic agent and/or an anticancer agent, wherein an electrolyte is topically administered through the nipple part into the mammary gland; subsequently, a donor is applied to the nipple part; and the active ingredient is topically administered through the nipple part into the mammary gland by application of current.

    摘要翻译: 提供用于治疗乳腺癌或乳腺炎的离子电渗疗法的治疗效果。 一种用于治疗乳腺癌和/或乳腺炎的离子电渗疗法制剂,其包含作为活性成分的非甾体抗炎止痛剂和/或抗癌剂,其中电解质通过乳头部分局部施用到乳腺中; 随后,将供体施加到乳头部分; 并且活性成分通过施加电流通过乳头部分局部施用到乳腺中。

    Iontophoretic preparation for treatment of breast cancer and/or mastitis
    13.
    发明授权
    Iontophoretic preparation for treatment of breast cancer and/or mastitis 失效
    用于治疗乳腺癌和/或乳腺炎的离子电渗疗法

    公开(公告)号:US08362027B2

    公开(公告)日:2013-01-29

    申请号:US13204803

    申请日:2011-08-08

    摘要: The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.

    摘要翻译: 本发明提供通过局部施用非甾体抗炎止痛剂和/或抗癌剂并使其有效地进入乳腺来治疗乳腺癌和/或乳腺炎的方法。 本发明提供了一种用于治疗乳腺癌和/或乳腺炎的离子电渗疗法,其包含非甾体抗炎止痛剂和/或抗癌剂作为活性成分,并且具有施用于乳头部分的供体,用于局部施用 通过施加电位从乳头部分到乳腺的活性成分。

    Indomethacin external preparation
    14.
    发明授权
    Indomethacin external preparation 有权
    吲哚美辛外用制剂

    公开(公告)号:US07553865B2

    公开(公告)日:2009-06-30

    申请号:US10521958

    申请日:2003-07-22

    摘要: An object of the present invention is to provide an indomethacin external preparation that has an excellent use feeling and excellent absorbability and causes no phase separation into an oil layer and an aqueous layer, thus exhibiting satisfactory stability of preparation with time. Provided is an indomethacin external preparation containing: 0.1 to 3 wt % of indomethacin; 25 to 50 wt % of alcohol; 0.01 to 5 wt % of gelling agent; 5 to 30 wt % of oil component; 20 to 50 wt % of water; and 0.01 to 10 wt % of one or more components selected from the group consisting of glyceryl monostearate, sorbitan monostearate, stearyl alcohol, and polyethylene glycol monostearate.

    摘要翻译: 本发明的目的是提供具有优异的使用感和优异的吸收性的吲哚美辛外用制剂,并且不会使相分离成油层和水层,从而表现出令人满意的制备时间稳定性。 本发明提供消炎痛外用制剂,含有0.1〜3重量%的吲哚美辛; 25〜50重量%的醇; 0.01〜5重量%的胶凝剂; 5〜30重量%的油成分; 20〜50重量%的水; 和0.01〜10重量%的选自单硬脂酸甘油酯,脱水山梨糖醇单硬脂酸酯,硬脂醇和聚乙二醇单硬脂酸酯的一种或多种成分。

    Solid dispersion composition
    16.
    发明授权
    Solid dispersion composition 失效
    固体分散体组成

    公开(公告)号:US06753330B2

    公开(公告)日:2004-06-22

    申请号:US10414008

    申请日:2003-04-16

    IPC分类号: A61K3150

    摘要: The invention provides a solid dispersion composition containing 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, hydroxypropylmethyl cellulose, and polyoxyethylene polyoxypropylene glycol. The solid dispersion composition of the present invention exhibits the excellent dissolvability of 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one in water, and enables this compound to be constant sequentially and thereby improve absorbability in blood.

    摘要翻译: 本发明提供了含有2-苄基-5-(4-氯苯基)-6- [4-(甲硫基)苯基] -2H-哒嗪-3-酮,羟丙基甲基纤维素和聚氧乙烯聚氧丙烯二醇的固体分散体组合物。 本发明的固体分散体组合物表现出2-苄基-5-(4-氯苯基)-6- [4-(甲硫基)苯基] -2H-哒嗪-3-酮在水中的优异的溶解性,使该化合物 依次保持恒定,从而提高血液中的吸收性。

    Local anesthetic for external use
    17.
    发明授权
    Local anesthetic for external use 失效
    局部麻醉用于外用

    公开(公告)号:US06429228B1

    公开(公告)日:2002-08-06

    申请号:US09284124

    申请日:1999-04-06

    IPC分类号: A61K31165

    摘要: A local anesthetic for external use is prepared by blending a) an active ingredient selected from lidocaine, prilocaine, and pharmaceutically acceptable salts thereof; b) a percutaneous absorption accelerator, c) ethanol and/or isopropyl alcohol, and d) water, such that the blending ratio of ethanol and/or isopropyl alcohol to water is 0.5 to 1.2 by weight, and the pH is 6.0 to 8.5.

    摘要翻译: 通过混合a)选自利多卡因,丙胺卡因及其药学上可接受的盐的活性成分,制备外用局部麻醉剂; b)经皮吸收促进剂,c)乙醇和/或异丙醇,和d)水,使得乙醇和/或异丙醇与水的混合比例为0.5至1.2重量%,pH为6.0至8.5。

    Hydrophilic adhesive base material
    18.
    发明授权
    Hydrophilic adhesive base material 失效
    亲水性胶粘剂基材

    公开(公告)号:US5773028A

    公开(公告)日:1998-06-30

    申请号:US671541

    申请日:1996-06-27

    摘要: Described is a hydrophilic adhesive base material comprising a hydrophilic crosslinked polymer obtained by polymerizing (A) (a) a glucosyloxyalkyl (meth)acrylate, (b) an alkyl (meth)acrylate and/or a hydroxyalkyl (meth)acrylate and (c) a polyfunctional monomer; and (B) polyvinyl alcohol. The hydrophilic adhesive base material according to the present invention is free from lowering in the water content and has excellent mechanical strength and adhesion to the skin so that it is useful as adhesive layers in plasters, various medical pads and also medicament-impregnated dermatologic medicines.

    摘要翻译: 描述了包含通过(A)(a)(甲基)丙烯酸葡糖基氧烷基酯,(b)(甲基)丙烯酸烷基酯和/或(甲基)丙烯酸羟烷基酯)和(c)聚合得到的亲水性交联聚合物的亲水性粘合剂基材, 多官能单体; 和(B)聚乙烯醇。 根据本发明的亲水性粘合剂基材不含水分降低,并且具有优异的机械强度和对皮肤的粘合性,因此其可用作石膏,各种医用垫中的粘合剂层以及药物浸渍的皮肤病学药物。

    Iontophoretic preparation for treatment of breast cancer and/or mastitis
    19.
    发明授权
    Iontophoretic preparation for treatment of breast cancer and/or mastitis 有权
    用于治疗乳腺癌和/或乳腺炎的离子电渗疗法

    公开(公告)号:US08034824B2

    公开(公告)日:2011-10-11

    申请号:US12089804

    申请日:2006-10-11

    摘要: The present invention is to provide means to treat breast cancer and/or mastitis by topically administering a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent and allowing them efficiently to arrive into the mammary gland. The present invention provides an iontophoretic preparation for treating breast cancer and/or mastitis which contains a non-steroidal antiinflammatory analgetic agent and/or an anticancer agent as an active ingredient and has a donor to be applied on a nipple part for topical administration of the active ingredient from the nipple part to the mammary gland by application of electric potential.

    摘要翻译: 本发明提供通过局部施用非甾体抗炎止痛剂和/或抗癌剂并使其有效地进入乳腺来治疗乳腺癌和/或乳腺炎的方法。 本发明提供了一种用于治疗乳腺癌和/或乳腺炎的离子电渗疗法,其包含非甾体抗炎止痛剂和/或抗癌剂作为活性成分,并且具有施用于乳头部分的供体,用于局部施用 通过施加电位从乳头部分到乳腺的活性成分。

    Composition for restoring damaged skin comprising a saccaride and povidone-iodine
    20.
    发明申请
    Composition for restoring damaged skin comprising a saccaride and povidone-iodine 审中-公开
    用于恢复损伤皮肤的组合物,其包含骶骨和聚维酮碘

    公开(公告)号:US20090317354A1

    公开(公告)日:2009-12-24

    申请号:US12583729

    申请日:2009-08-25

    IPC分类号: A61K31/79 A61P17/02

    CPC分类号: A61K45/06 A61K31/79 A61K33/18

    摘要: The present invention relates to a composition for repairing injured skin containing a saccharide and povidone-iodine. The present invention has the following characteristics: suppresses time-dependent increase of consistency, it is easy to use, it is a soft preparation, and has superior applicability to a deep wounded lesion and a granulation tissue. The composition of the present invention contains 50 to 90% by weight of saccharide, 0.5 to 10% by weight of povidone-iodine, 0.1 to 20% by weight of water and 0.01 to 10% by weight of phospholipid.

    摘要翻译: 本发明涉及用于修复含有糖和聚维酮碘的受伤皮肤的组合物。 本发明具有以下特征:抑制时间依赖性增加,易于使用,是一种柔软的制剂,对深部伤口和肉芽组织具有优异的适用性。 本发明的组合物含有50〜90重量%的糖类,0.5〜10重量%的聚维酮碘,0.1〜20重量%的水和0.01〜10重量%的磷脂。